{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:29:40Z","timestamp":1778624980486,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,6,3]]},"DOI":"10.1038\/s41388-026-03776-y","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:34:03Z","timestamp":1776173643000},"page":"1914-1929","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blocking ubiquitination of hnRNPA1 maintains the self-renewal of breast cancer stem cells via mutually exclusive splicing of PKM pre-mRNA"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1017-4560","authenticated-orcid":false,"given":"Xuemei","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3654-171X","authenticated-orcid":false,"given":"Li","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Wei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dikang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haishan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2216-2794","authenticated-orcid":false,"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7258-3207","authenticated-orcid":false,"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"3776_CR1","doi-asserted-by":"publisher","unstructured":"Martelotto LG, Ng CKY, Piscuoglio S, Weigelt B, Reis JS. Breast cancer intra-tumor heterogeneity. Breast Cancer Res. 16, https:\/\/doi.org\/10.1186\/bcr3658 (2014).","DOI":"10.1186\/bcr3658"},{"key":"3776_CR2","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1172\/Jci60534","volume":"121","author":"K Polyak","year":"2011","unstructured":"Polyak K. Heterogeneity in breast cancer. J Clin Investig. 2011;121:3786\u20138. https:\/\/doi.org\/10.1172\/Jci60534.","journal-title":"J Clin Investig"},{"key":"3776_CR3","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1172\/Jci57099","volume":"121","author":"H Korkaya","year":"2011","unstructured":"Korkaya H, Liu SL, Wicha MS. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Investig. 2011;121:3804\u20139. https:\/\/doi.org\/10.1172\/Jci57099.","journal-title":"J Clin Investig"},{"key":"3776_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2009.12.007","volume":"140","author":"S Pece","year":"2010","unstructured":"Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell. 2010;140:62\u201373. https:\/\/doi.org\/10.1016\/j.cell.2009.12.007.","journal-title":"Cell"},{"key":"3776_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.stem.2015.08.014","volume":"17","author":"MD Brooks","year":"2015","unstructured":"Brooks MD, Burness ML, Wicha MS. Therapeutic implications of cellular heterogeneity and plasticity in breast cancer. Cell Stem Cell. 2015;17:260\u201371. https:\/\/doi.org\/10.1016\/j.stem.2015.08.014.","journal-title":"Cell Stem Cell"},{"key":"3776_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1158\/1078-0432.Ccr-09-1630","volume":"16","author":"E Charafe-Jauffret","year":"2010","unstructured":"Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res. 2010;16:45\u201355. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-09-1630.","journal-title":"Clin Cancer Res"},{"key":"3776_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/science.adr2428","volume":"390","author":"HYG Lim","year":"2025","unstructured":"Lim HYG, Yada S, Murakami K, Lee BTK, Sagiraju S, Phuah P, et al. AQP5: a functional gastric cancer stem cell marker in mouse and human tumors. Science. 2025;390:eadr2428. https:\/\/doi.org\/10.1126\/science.adr2428.","journal-title":"Science"},{"key":"3776_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2106","volume":"10","author":"MJ Grimshaw","year":"2008","unstructured":"Grimshaw MJ, Cooper L, Papazisis K, Coleman JA, Bohnenkamp HR, Chiapero-Stanke L, et al. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res. 2008;10:R52. https:\/\/doi.org\/10.1186\/bcr2106.","journal-title":"Breast Cancer Res"},{"key":"3776_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1059.","journal-title":"Cancer Discov"},{"key":"3776_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41568-024-00786-4","volume":"25","author":"P Altea-Manzano","year":"2025","unstructured":"Altea-Manzano P, Decker-Farrell A, Janowitz T, Erez A. Metabolic interplays between the tumour and the host shape the tumour macroenvironment. Nat Rev Cancer. 2025;25:274\u201392. https:\/\/doi.org\/10.1038\/s41568-024-00786-4.","journal-title":"Nat Rev Cancer"},{"key":"3776_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314. https:\/\/doi.org\/10.1126\/science.123.3191.309.","journal-title":"Science"},{"key":"3776_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.285","volume":"5","author":"D Ciavardelli","year":"2014","unstructured":"Ciavardelli D, Rossi C, Barcaroli D, Volpe S, Consalvo A, Zucchelli M, et al. Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment. Cell Death Dis. 2014;5:e1336. https:\/\/doi.org\/10.1038\/cddis.2014.285.","journal-title":"Cell Death Dis"},{"key":"3776_CR13","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/stem.1662","volume":"32","author":"W Feng","year":"2014","unstructured":"Feng W, Gentles A, Nair RV, Huang M, Lin Y, Lee CY, et al. Targeting unique metabolic properties of breast tumor initiating cells. Stem Cells. 2014;32:1734\u201345. https:\/\/doi.org\/10.1002\/stem.1662.","journal-title":"Stem Cells"},{"key":"3776_CR14","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/0008-5472.Can-23-2390","volume":"84","author":"LL Yan","year":"2024","unstructured":"Yan LL, Wu MM, Wang TY, Yuan H, Zhang X, Zhang HF, et al. Breast cancer stem cells secrete MIF to mediate tumor metabolic reprogramming that drives immune evasion. Cancer Res. 2024;84:1270\u201385. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-2390.","journal-title":"Cancer Res"},{"key":"3776_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nature08697","volume":"463","author":"CJ David","year":"2010","unstructured":"David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 2010;463:364\u2013U114. https:\/\/doi.org\/10.1038\/nature08697.","journal-title":"Nature"},{"key":"3776_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature06734","volume":"452","author":"HR Christofk","year":"2008","unstructured":"Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008;452:230\u2013U274. https:\/\/doi.org\/10.1038\/nature06734.","journal-title":"Nature"},{"key":"3776_CR17","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/s41388-023-02652-3","volume":"42","author":"YX Ma","year":"2023","unstructured":"Ma YX, Zhu YY, Shang L, Qiu Y, Shen N, Wang JAT, et al. LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6\/STAT3 signaling. Oncogene. 2023;42:1419\u201337. https:\/\/doi.org\/10.1038\/s41388-023-02652-3.","journal-title":"Oncogene"},{"key":"3776_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43113-5","volume":"14","author":"LH Liu","year":"2023","unstructured":"Liu LH, Liu ZY, Liu QH, Wu W, Lin P, Liu X, et al. LncRNA INHEG promotes glioma stem cell maintenance and tumorigenicity through regulating rRNA 2\u2019-O-methylation. Nat Commun. 2023;14:7526. https:\/\/doi.org\/10.1038\/s41467-023-43113-5.","journal-title":"Nat Commun"},{"key":"3776_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2020.12.012","volume":"75","author":"EM McCabe","year":"2021","unstructured":"McCabe EM, Rasmussen TP. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol. 2021;75:38\u201348. https:\/\/doi.org\/10.1016\/j.semcancer.2020.12.012.","journal-title":"Semin Cancer Biol"},{"key":"3776_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216826","volume":"590","author":"GB Gao","year":"2024","unstructured":"Gao GB, Chen L, Pan JF, Lei T, Cai X, Hao ZX, et al. LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer. Cancer Lett. 2024;590:216826. https:\/\/doi.org\/10.1016\/j.canlet.2024.216826.","journal-title":"Cancer Lett"},{"key":"3776_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01939-7","volume":"23","author":"ZH Bian","year":"2024","unstructured":"Bian ZH, Yang F, Xu PW, Gao G, Yang CY, Cao YL, et al. LINC01852 inhibits the tumorigenesis and chemoresistance in colorectal cancer by suppressing SRSF5-mediated alternative splicing of PKM. Mol Cancer. 2024;23:23. https:\/\/doi.org\/10.1186\/s12943-024-01939-7.","journal-title":"Mol Cancer"},{"key":"3776_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00571-3","volume":"12","author":"H Feng","year":"2024","unstructured":"Feng H, Xu DF, Jiang CY, Chen YM, Wang JR, Ren ZR, et al. LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin. Biomark Res. 2024;12:19. https:\/\/doi.org\/10.1186\/s40364-024-00571-3.","journal-title":"Biomark Res"},{"key":"3776_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi3821","volume":"9","author":"ZJ Cai","year":"2023","unstructured":"Cai ZJ, Shi QF, Li YD, Jin L, Li SY, Wong LL, et al. LncRNA EILA promotes CDK4\/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein. Sci Adv. 2023;9:eadi3821. https:\/\/doi.org\/10.1126\/sciadv.adi3821.","journal-title":"Sci Adv"},{"key":"3776_CR24","doi-asserted-by":"publisher","unstructured":"Zhang H, Chen ZH, Wang XX, Huang ZN, He ZW, Chen YQ. Long non-coding RNA: a new player in cancer. J Hematol Oncol. 6, 37 https:\/\/doi.org\/10.1186\/1756-8722-6-37 (2013).","DOI":"10.1186\/1756-8722-6-37"},{"key":"3776_CR25","doi-asserted-by":"publisher","first-page":"100851","DOI":"10.1016\/j.drup.2022.100851","volume":"63","author":"D Singh","year":"2022","unstructured":"Singh D, Assaraf YG, Gacche RN. Long non-coding RNA mediated drug resistance in breast cancer. Drug Resist Update. 2022;63:100851 https:\/\/doi.org\/10.1016\/j.drup.2022.100851.","journal-title":"Drug Resist Update"},{"key":"3776_CR26","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/ni.3654","volume":"18","author":"J Fang","year":"2017","unstructured":"Fang J, Bolanos LC, Choi KM, Liu XN, Christie S, Akunuru S, et al. Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia. Nat Immunol. 2017;18:236\u201345. https:\/\/doi.org\/10.1038\/ni.3654.","journal-title":"Nat Immunol"},{"key":"3776_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"HY Zhang","year":"2020","unstructured":"Zhang HY, Deng T, Liu R, Ning T, Yang HO, Liu DY, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19:43. https:\/\/doi.org\/10.1186\/s12943-020-01168-8.","journal-title":"Mol Cancer"},{"key":"3776_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10120-023-01437-7","volume":"27","author":"R Xie","year":"2024","unstructured":"Xie R, Liu L, Lu X, He C, Yao H, Li G. N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation. Gastric Cancer. 2024;27:49\u201371. https:\/\/doi.org\/10.1007\/s10120-023-01437-7.","journal-title":"Gastric Cancer"},{"key":"3776_CR29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1042\/CS20140592","volume":"129","author":"M He","year":"2015","unstructured":"He M, Fu Y, Yan Y, Xiao Q, Wu H, Yao W, et al. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients. Clin Sci. 2015;129:809\u201322. https:\/\/doi.org\/10.1042\/CS20140592.","journal-title":"Clin Sci"},{"key":"3776_CR30","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1111\/cas.13633","volume":"109","author":"T Lu","year":"2018","unstructured":"Lu T, Wu B, Yu Y, Zhu W, Zhang S, Zhang Y, et al. Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis. Cancer Sci. 2018;109:2221\u201334. https:\/\/doi.org\/10.1111\/cas.13633.","journal-title":"Cancer Sci"},{"key":"3776_CR31","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1111\/jcmm.15261","volume":"24","author":"L Han","year":"2020","unstructured":"Han L, Yan Y, Zhao L, Liu Y, Lv X, Zhang L, et al. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p\/WNT1 pathway. J Cell Mol Med. 2020;24:6242\u201352. https:\/\/doi.org\/10.1111\/jcmm.15261.","journal-title":"J Cell Mol Med"},{"key":"3776_CR32","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.2174\/1568026623666230712120527","volume":"23","author":"C Guo","year":"2023","unstructured":"Guo C, Wu L, Zheng X, Zhao L, Hou X, Wang Z, et al. Research progress on small-molecule inhibitors of protein arginine methyltransferase 5 (PRMT5) for Treating Cancer. Curr Top Med Chem. 2023;23:2048\u201374. https:\/\/doi.org\/10.2174\/1568026623666230712120527.","journal-title":"Curr Top Med Chem"},{"key":"3776_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1158\/0008-5472.Can-21-0403","volume":"82","author":"Y Xia","year":"2022","unstructured":"Xia Y, Wang X, Liu Y, Shapiro E, Lepor H, Tang MS, et al. PKM2 is essential for bladder cancer growth and maintenance. Cancer Res. 2022;82:571\u201385. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-0403.","journal-title":"Cancer Res"},{"key":"3776_CR34","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/0008-5472.Can-20-0948","volume":"82","author":"WK Ma","year":"2022","unstructured":"Ma WK, Voss DM, Scharner J, Costa ASH, Lin KT, Jeon HY, et al. ASO-based PKM splice-switching therapy inhibits hepatocellular carcinoma growth. Cancer Res. 2022;82:900\u201315. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-0948.","journal-title":"Cancer Res"},{"key":"3776_CR35","doi-asserted-by":"publisher","first-page":"8159","DOI":"10.1007\/s13277-015-4729-8","volume":"37","author":"TY Dong","year":"2016","unstructured":"Dong TY, Kang XM, Liu ZL, Zhao S, Ma WJ, Xuan QJ, et al. Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer. Tumor Biol. 2016;37:8159\u201368. https:\/\/doi.org\/10.1007\/s13277-015-4729-8.","journal-title":"Tumor Biol"},{"key":"3776_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abp9153","volume":"8","author":"AN Jones","year":"2022","unstructured":"Jones AN, Grass C, Meininger I, Geerlof A, Klostermann M, Zarnack K, et al. Modulation of pre-mRNA structure by hnRNP proteins regulates alternative splicing of. Sci Adv. 2022;8:eabp9153. https:\/\/doi.org\/10.1126\/sciadv.abp9153.","journal-title":"Sci Adv"},{"key":"3776_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21:141\u201362. https:\/\/doi.org\/10.1038\/s41573-021-00339-6.","journal-title":"Nat Rev Drug Discov"},{"key":"3776_CR38","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","volume":"35","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Yu TJ, Xu Y, Ding R, Wang YP, Jiang YZ, et al. Emerging therapies in cancer metabolism. Cell Metab. 2023;35:1283\u2013303. https:\/\/doi.org\/10.1016\/j.cmet.2023.07.006.","journal-title":"Cell Metab"},{"key":"3776_CR39","doi-asserted-by":"publisher","first-page":"e161454","DOI":"10.1172\/JCI161454","volume":"132","author":"R Pirlog","year":"2022","unstructured":"Pirlog R, Calin GA. KRAS mutations as essential promoters of lymphangiogenesis via extracellular vesicles in pancreatic cancer. J Clin Investig. 2022;132:e161454 https:\/\/doi.org\/10.1172\/JCI161454.","journal-title":"J Clin Investig"},{"key":"3776_CR40","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3892\/or.2018.6273","volume":"39","author":"YH Chen","year":"2018","unstructured":"Chen YH, Liu J, Wang W, Xiang L, Wang JD, Liu SD, et al. High expression of hnRNPA1 promotes cell invasion by inducing EMT in gastric cancer. Oncol Rep. 2018;39:1693\u2013701. https:\/\/doi.org\/10.3892\/or.2018.6273.","journal-title":"Oncol Rep"},{"key":"3776_CR41","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.7150\/thno.34813","volume":"9","author":"XT Gao","year":"2019","unstructured":"Gao XT, Wan Z, Wei MY, Dong Y, Zhao YX, Chen XT, et al. Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320. Theranostics. 2019;9:5642\u201356. https:\/\/doi.org\/10.7150\/thno.34813.","journal-title":"Theranostics"},{"key":"3776_CR42","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/ijms25031587","volume":"25","author":"C Tous","year":"2024","unstructured":"Tous C, Mu\u00f1oz-Redondo C, Gavil\u00e1n A, Bravo-Gil N, Baco-Ant\u00f3n F, Navarro-Gonz\u00e1lez E, et al. Delving into the role of lncRNAs in papillary thyroid cancer: upregulation of LINC00887 promotes cell proliferation, growth and invasion. Int J Mol Sci. 2024;25:1587 https:\/\/doi.org\/10.3390\/ijms25031587.","journal-title":"Int J Mol Sci"},{"key":"3776_CR43","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/2211-5463.12930","volume":"10","author":"JJ Xie","year":"2020","unstructured":"Xie JJ, Zhong Y, Chen R, Li G, Luo YW, Yang JT, et al. Serum long non-coding RNA LINC00887 as a potential biomarker for diagnosis of renal cell carcinoma. Febs Open Biol. 2020;10:1802\u20139. https:\/\/doi.org\/10.1002\/2211-5463.12930.","journal-title":"Febs Open Biol"},{"key":"3776_CR44","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41419-024-07091-w","volume":"15","author":"MJ Liao","year":"2024","unstructured":"Liao MJ, Zheng WD, Wang YF, Li MT, Sun XL, Liu N, et al. LINC00887 promotes GCN5-dependent H3K27cr level and CRC metastasis via recruitment of YEATS2 and enhancing ETS1 expression. Cell Death Dis. 2024;15:711 https:\/\/doi.org\/10.1038\/s41419-024-07091-w.","journal-title":"Cell Death Dis"},{"key":"3776_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12572","volume":"23","author":"M Hayashi-Okada","year":"2024","unstructured":"Hayashi-Okada M, Sato S, Nakashima K, Sakai T, Tamehisa T, Kajimura T, et al. Identification of long noncoding RNAs downregulated specifically in ovarian high-grade serous carcinoma. Reprod Med Biol. 2024;23:e12572. https:\/\/doi.org\/10.1002\/rmb2.12572.","journal-title":"Reprod Med Biol"},{"key":"3776_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01730-w","volume":"21","author":"P Li","year":"2021","unstructured":"Li P, Wang JS, Zhi LR, Cai FM. Linc00887 suppresses tumorigenesis of cervical cancer through regulating the miR-454-3p\/FRMD6-Hippo axis. Cancer Cell Int. 2021;21:33. https:\/\/doi.org\/10.1186\/s12935-020-01730-w.","journal-title":"Cancer Cell Int"},{"key":"3776_CR47","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3892\/or.2019.7228","volume":"42","author":"Y Tian","year":"2019","unstructured":"Tian Y, Yu M, Sun L, Liu L, Huo S, Shang W, et al. Long non\u2011coding RNA00887 reduces the invasion and metastasis of non\u2011small cell lung cancer by causing the degradation of miRNAs. Oncol Rep. 2019;42:1173\u201382. https:\/\/doi.org\/10.3892\/or.2019.7228.","journal-title":"Oncol Rep"},{"key":"3776_CR48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/Igc.0000000000000868","volume":"27","author":"YJ Kim","year":"2017","unstructured":"Kim YJ, Kim BR, Ryu JS, Lee GO, Kim HR, Choi KH, et al. HNRNPA1, a splicing regulator, is an effective target protein for cervical cancer detection. Int J Gynecol Cancer. 2017;27:326\u201331. https:\/\/doi.org\/10.1097\/Igc.0000000000000868.","journal-title":"Int J Gynecol Cancer"},{"key":"3776_CR49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semcancer.2022.12.011","volume":"88","author":"CH Liao","year":"2023","unstructured":"Liao CH, Liu XJ, Zhang C, Zhang Q. Tumor hypoxia: from basic knowledge to therapeutic implications. Semin Cancer Biol. 2023;88:172\u201386. https:\/\/doi.org\/10.1016\/j.semcancer.2022.12.011.","journal-title":"Semin Cancer Biol"},{"key":"3776_CR50","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","volume":"145","author":"WB Luo","year":"2011","unstructured":"Luo WB, Hu HX, Chang R, Zhong J, Knabel M, O\u2019Meally R, et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell. 2011;145:732\u201344. https:\/\/doi.org\/10.1016\/j.cell.2011.03.054.","journal-title":"Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03776-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03776-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03776-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:03:17Z","timestamp":1778623397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03776-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":50,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026,6,3]]}},"alternative-id":["3776"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03776-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7722676\/v1","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. All animal experiments were performed in accordance with the relevant institutional and national guidelines and the regulations of the Medical Laboratory Animal Health Committee of China Medical University (CMU20241515). Informed consent was obtained from all participants whose tissue samples were used in this study. This study was approved by the Clinical Research Ethics Committee of China Medical University (No. 2019080). This study was approved by the Ethics Committee of the First Affiliated Hospital of China Medical University (Approval Number: AF-SOP-07-1.1-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All of the authors have written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}